Hypoglycemic and High Dosage Effects of Bidens pilosa in Type-1 Diabetes Mellitus

Simple item page
dc.contributor.authorAjagun-Ogunleye, Mulkah O.
dc.contributor.authorTirwomwe, Michael
dc.contributor.authorMitak, Ruth Nyaboke
dc.contributor.authorKasozi, Keneth Iceland
dc.contributor.authorMbiydzenyuy, Elvis Ngala
dc.date.accessioned2022-09-14T10:35:17Z
dc.date.available2022-09-14T10:35:17Z
dc.date.issued2015
dc.description.abstractEthno-pharmaceutical products have received a lot of international attention in the scientific com- munity in the management of diabetes mellitus (DM). In this study we determined the anti-dia- betic and high dosage effects of Bidens pliosa in type 1 DM (T1DM). Methodology: Thirty rats were divided into six groups and subgrouped into the extract and non extract treatment groups. The extract treated group was subdivided into three groups which received 200 mg/kg, 400 mg/ kg and 800 mg/kg dosage treatments respectively. The blood glucose levels were monitored using a standard glucometer for one month, and biochemical analysis of the two liver function enzymes; Alanine aminotransferase (ALT) and Aspartate aminotransferase (AST) were carried out at the Institute of Biomedical Research (IBR-KIU-WC) at the end of week IV. The study revealed that Bidens pilosa maintained hypoglycemia for a period of two weeks and this status was lost in subsequent weeks. T1DM rats treated with a dosage of 200 mg/kg showed a better recovery (355.25 - 164.5 mg/dl) of the glucose levels, followed by those that were being treated at 400 mg/kg. The AST and ALT enzymes in blood varied with a mean ± SEM (33.72 ± 32.32 to −7.23 ± 12.61 IU and 22.98 ± 11.12 to 42 ± 38.2 IU, respectively) in both the glibencimide® and in the 800 mg/ kg treatment groups in the study. High dosages of extract were associated (P = 0.049) with increased systemic enzyme leakage. In conclusion, tissue degeneration caused by high levels of the extract was accompanied by leakage of various enzymes (AST and ALT) into the blood, which could be a major etiological factor for the development of secondary systemic pathologies, thus potentially worsening the effects of an existing T1DM prognosis in human patients. The preliminary results indicate that a dose of Bidens pilosa has an anti-diabetic effect for a limited initial duration before starting to cause systemic toxicological effects. It is highly recommended that further investigation into the cellular mechanisms and consequences of any therapy involving Bidens pilosa be carried out.en_US
dc.identifier.citationAjagun-Ogunleye, M. O., Tirwomwe, M., Mitaki, R. N., Ejekwumadu, J. N., Kasozi, K. I., Pantoglou, J., ... & Mitaki, N. B. (2015). Hypoglycemic and high dosage effects of bidens pilosa in type-1 diabetes mellitus. Journal of Diabetes Mellitus, 5(03), 146.http://dx.doi.org/10.4236/jdm.2015.53018en_US
dc.identifier.urihttps://nru.uncst.go.ug/handle/123456789/4725
dc.language.isoenen_US
dc.publisherJournal of Diabetes Mellitusen_US
dc.subjectType 1 Diabetes Mellitus, Bidens pilosa and Diabetes, Ethno-Pharmaceutical Medicine in Uganda, Sub-Saharan Africa and Diabetesen_US
dc.titleHypoglycemic and High Dosage Effects of Bidens pilosa in Type-1 Diabetes Mellitusen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Hypoglycemic and High Dosage Effects of Bidens pilosa in Type-1 Diabetes Mellitus.pdf
Size:
550.1 KB
Format:
Adobe Portable Document Format
Description:
Hypoglycemic and High Dosage Effects of Bidens pilosa in Type-1 Diabetes Mellitus
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Medical and Health Sciences